Jody Aufrichtig
Co-Founder, Executive Chairman and Director

Jody is an award-winning entrepreneur, business builder, impact investor, and philanthropist. A Chartered Accountant by training, he has built significant and rapid shareholder value in 19 businesses in a broad range of sectors including cannabis, private equity, travel and tourism, sport and leisure, as well as other industries. Jody previously headed up Canopy Growth’s African operations.

Christopher Bull
Independant Director

Christopher is a qualified chemical engineer, attorney, patent attorney and Certified Licensing Professional®, he is also an alumnus of Said Business School, Oxford University (Private Equity and Venture Capital). Over his 30-year career he has been an investor, director, founder and advisor to a range of successful companies in Europe and North America with novel technologies in the fields of pharmaceuticals, biotechnology, food sciences, chemical processing, and extraction technologies. He is recognised for his skills in relation to the development and execution of venture capital investment, patent and intellectual property strategies for high-technology companies and has received a number of international awards in recognition of this.

Seth Feuerstein
Board Member

Dr. Feuerstein has expertise across multiple areas of medicine. He is Faculty at Yale School of Medicine in the Department of Psychiatry. He is a founding board member of the Center for Biomedical and Interventional Technology at Yale and Executive Director of the Center for Digital Health, Innovation and Excellence. He teaches at the medical school and is the faculty advisor for Innovation in Healthcare at the Yale School of Medicine.

He works across multiple sectors in healthcare including health insurance, healthcare startups, healthcare investing, clinical care delivery innovation and early stage emerging medical technologies. He has serial successes for novel reimbursement in healthcare and is a Former C suite executive at a national health insurer.

Marc Balkin
Board Member

Experienced Non Executive Director with a demonstrated history of working in the management consulting industry. Skilled in Emerging Markets, Entrepreneurship, Venture Capital, Private Equity, and Start-ups. Strong business development professional graduated from University of the Witwatersrand. Partner Di-Game and Former Partner Hasso Plattner Ventures. Mark has served on the investment committees of Enablis, First National Bank Vumela FutureMaker and Alithea IDF. He is also a Newcourt Board Member

Jody Aufrichtig
Co-Founder, Executive Chairman and Director

Jody is an award-winning entrepreneur, business builder, impact investor, and philanthropist. A Chartered Accountant by training, he has built significant and rapid shareholder value in 19 businesses in a broad range of sectors including cannabis, private equity, travel and tourism, sport and leisure, as well as other industries. Jody previously headed up Canopy Growth’s African operations.

Taryn Vos
General Counsel

Taryn is a commercial and corporate attorney and oversees all legal and commercial administrative agreements for the company. She was previously Head of Legal, for Canopy Growth Africa. After working as an associate at Cliffe Dekker Hofmeyr, in Cape Town, she joined Solar Capital, a renewable energy company, as in-house legal counsel. Taryn has also served as legal advisor to Phelan Energy Group, Ltd.

Warwick Corden-Lloyd
Chief Financial Officer

Warwick is a Chartered Accountant and Certified Project Manager with over 17 years of work experience in the United Kingdom, the USA, and South Africa. Warwick brings a wide scope of experience ranging from advising the boards of publicly traded companies to strategy design for start-ups. Warwick served as VP Operations and Finance for Canopy Growth Africa and prior to that was the Head of Financial Accounting for Capitec Bank. He is also a CA charter holder from The South African Institute of Chartered Accountants and a member of The Institute of Chartered Accountants in England and Wales.

Dr. Clive Ward-Able
Medical Director

Dr Clive Ward-Able is a physician and a pharmacist who has worked in the pharmaceutical industry for over 30 years with 23 of those at the executive level. He has worked in large and small pharmaceutical and biotechnology companies in Canada, US, UK, Switzerland and South Africa in the departments of R&D, medical affairs, marketing and sales.

His experience relates mostly to the medical aspect of therapeutic drug commercialization and has been involved with the launch of over 16 products in multiple therapeutic areas. He is the President of his consultant company, Clintell Inc, and has been acting as consultant Medical Director for numerous start-up companies for the past 4 years. He is currently a member of the Board of Directors for Clinical Trials Ontario.

Mary-Elizabeth Gifford
Chief of Global Impact

Mary-Elizabeth is chair of the Global Wellness Institute’s Psychedelics & Healing Initiative. She joined the team at Psyence in 2020 from the Washington, DC, nonprofit, The Center for Mind-Body Medicine, global experts in trauma healing. Co-author of the Nature vs. Synthetic Psilocybin chapter in the recent Springer Nature textbook on therapeutic mushrooms, she regularly publishes on palliative psilocybin policy issues.

A collaborative voice for mental health on Capitol Hill and elsewhere, she was named a “Psychedelic Titan,” one of “the psychedelic industry’s most influential and impactful individuals,” by Microdose; Spirituality & Health Magazine describes Mary-Elizabeth as “the most quietly influential woman working in psychedelics today.” Educated at Brown University, she had a post-graduate year of study at Harvard. She lives in New York CIty and Washington, D.C.